+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Succeeding in the Italy Hepatitis Diagnostic Testing Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence

  • PDF Icon

    Report

  • 241 Pages
  • June 2019
  • Region: Italy
  • VPG Market Research
  • ID: 4135736
The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

The report provides five year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti- HBc, Anti- HBs, Anti- HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
  • Hospitals

  • Commercial/Private Labs

  • Blood Banks


In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Companies Mentioned

  • Abbott

  • Affymetrix

  • Beckman Coulter/Danaher

  • Becton Dickinson

  • bioMerieux

  • Bio-Rad

  • Cepheid

  • Diamedix

  • DiaSorin

  • Eiken Chemical

  • Elitech Group

  • Enzo Biochem

  • Fujirebio

  • Grifols

  • GSK Biologicals

  • Hologic

  • Leica Biosystems

  • Lonza

  • Ortho-Clinical Diagnostics

  • PerkinElmer

  • Qiagen

  • Roche

  • Scienion

  • Sequenom

  • SeraCare

  • Siemens Healthineers

  • Takara Bio

  • Thermo Fisher

  • Wako